| ID: | 71 | |
|---|---|---|
| Name: | Compound 71 | |
| Description: | Original numeration in publication: 27c | |
| Labels: | Training_set, Quinoxalines | |
| CAS: | ||
| InChi Code: | InChI=1S/C26H24N4O5/c1-16-26(33)30(20-8-5-4-7-19(20)27-16)15-23(31)28-18-13-11-17(12-14-18)25(32)29-24-21(34-2)9-6-10-22(24)35-3/h4-14H,15H2,1-3H3,(H,28,31)(H,29,32) |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 7.94 |
Alanazi, M. M.; Eissa, I. H.; Alsaif, N. A. a. O., A. J.; Alanazi, W. A.; Alasmari, A. F. a. A., H.; Elkady, H.; Elwan, A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzyme Inhib. Med. Chem. 2021, 36, 1760–1782. https://doi.org/10.1080/14756366.2021.1956488 |
| 7.04325 |
Eq1: VEGFR-2 inhibition (Data used to train model) |